The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 13, 2024

Filed:

Apr. 21, 2017
Applicant:

Valcuria Ab, Lund, SE;

Inventors:

Johan Drott, Bjärred, SE;

Kristina Drott, Lund, SE;

Stefan Ulvenlund, Lund, SE;

Catharina Salomonsson, Lund, SE;

Assignee:

VALCURIA AB, Lund, SE;

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 9/50 (2006.01); A61K 31/19 (2006.01); A61K 31/20 (2006.01); A61K 31/573 (2006.01); A61K 45/06 (2006.01); A61K 47/38 (2006.01); A61P 35/00 (2006.01);
U.S. Cl.
CPC ...
A61K 9/5084 (2013.01); A61K 9/5026 (2013.01); A61K 9/5047 (2013.01); A61K 31/19 (2013.01); A61K 31/20 (2013.01); A61K 31/573 (2013.01); A61K 45/06 (2013.01); A61K 47/38 (2013.01); A61P 35/00 (2018.01);
Abstract

The present invention relates to a pharmaceutical composition comprising an HDAC inhibitor, a pharmaceutically acceptable acid or salt thereof or a mixture of the acid and salt, provided both in a immediate release form and in an extended release form wherein 70-90 weight % of the HDAC inhibitor is provided in the immediate release form and the remainder of the HDAC inhibitor is provided in the extended release form. In further aspects the present invention relates to a kit comprising a number of doses of an HDAC inhibitor, a pharmaceutically acceptable acid or salt thereof or a mixture of the acid and salt thereof provided both in an immediate release form and in an extended release form. In still further aspects the present invention relates to an HDAC inhibitor, a pharmaceutically acceptable acid or salt thereof or a mixture of the acid and salt, provided in both an immediate release form and an extended release form, for use in a method of pretreating cancer, and a method of pretreating cancer using said HDAC inhibitor provided both in said immediate release form and said extended release form. Further aspects relate to combination treatment of cancer and to a dispenser for a blister pack.


Find Patent Forward Citations

Loading…